However, we observed AT1-AA and ACE2-AA in the cerebrospinal fluid (CSF) of PD models and PD patients in previous studies [13,14], and more recently, we observed AT2-AA and MasR-AA in post-COVID patients, where we observed correlations with levels of serum RAS-AAs [57]. This evidence concerns the gene AGTR2 and Parkinson disease.